SUMMARY In this study we attempted to determine if the cold pressor test, a known sympathetic reflexogenic stimulus, could precipitate coronary artery spasm. Thirty-five patients undergoing coronary arteriography for evaluation of chest pain syndromes were given the cold pressor test. During 1 minute of cold pressor stimulation, aortic systolic pressure increased 18.1 ± 9.7 mm Hg (mean ± SD) and heart rate did not change significantly. Focal coronary artery spasm was provoked in seven patients, each of whom had an atheromatous plaque at the site of spasm. Four of six patients with a precatheterization clinical diagnosis of variant angina (group 1) had coronary artery spasm, and two of the four had associated ischemic manifestations. Of 14 patients in whom classic angina (group 2) was diagnosed before cardiac catheterization, two manifested focal coronary spasm. One of 15 patients thought to have atypical chest pain (group 3) manifested spasm. There were no significant differences in baseline variables (aortic systolic or diastolic pressure, heart rate, double product and left ventricular end-diastolic pressure) or hemodynamic response (aortic systolic pressure, heart rate or double product) to cold pressor stimulation between patients in each group and between those who manifested spasm and those who did not. Ventricular ectopy and ventricular tachycardia developed in one patient but were readily reversed with intravenous nitroglycerin. Quantitative angiography showed that the luminal diameter of normal coronary segments significantly decreased in each group of patients in response to cold pressor stimulation, but this response was most pronounced in the variant angina group (-12.7 ± 11.5% from control in group 1, -5.1 ± 10.2% in group 2, and -7.9 ± 9.6% in group 3; p < 0.001 for each group). Patients who are prone to coronary spasm may represent one extreme of a spectrum of reactivity to a coronary vasoconstrictive stimulus. The cold pressor test can provoke focal coronary artery spasm in certain patients and may be a useful nonpharmacologic provocative screening test to aid in the diagnosis of this phenomenon.
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CORONARY ARTERY SPASM has become the focus of increasing attention. Its role in variant angina is well documented,'-' and it has been observed in patients with classic angina,6 7 unstable angina8 9 and myocardial infarction.10 The transience of coronary artery spasm makes it difficult to diagnose. Consequently, various interventions, primarily pharmacologic, have been used to provoke coronary artery spasm during coronary arteriography. These pharmacologic interventions include the administration of ergot aklaloids,", 12 epinephrine in combination with propranolol,13 and methacholine.14 The cold pressor test, a sympathetic reflexogenic stimulus, has been shown to increase coronary resistance and reduce coronary blood flow in patients with coronary artery disease, presumably by reflex coronary vasoconstriction. 15 The present study was undertaken to determine whether the cold pressor test could precipitate focal coronary spasm and therefore provide a useful, nonpharmacologic provocative test to aid in the diagnosis of this phenomenon. Additionally, the general response of normal and diseased coronary arteries to the cold pressor test was measured using quantitative arteriographic techniques.
sidered to have variant angina based on anginal chest pain that usually occurred at rest but might also be provoked by effort and ST-segment elevation, rather than the usual ST depression, during chest pain. Group 2 consisted of 14 patients considered to have classic angina pectoris based on chest pain with effort typical of angina pectoris and ST-segment depression accompanying the chest pain during a treadmill exercise test. Group 3 consisted of 15 patients with atypical chest pain and no definite electrocardiographic manifestations of ischemia.
Cardiac catheterization was performed with the patient in the fasting state after informed consent had been obtained. No routine premedication was administered. Left-heart pressures were measured before arteriography. Selected coronary arteriograms were then obtained in several oblique projections. Next, the cold pressor test was performed by submersing the patient's free hand in ice water for 1 minute while monitoring aortic pressure and two electrocardiographic leads (usually leads I and III). After 1 minute of cold submersion, aortic pressure and heart rate were measured. The catheter was then manipulated to the coronary orifice and an arteriogram was obtained in a selected oblique projection. The patient's hand was removed from the water between coronary injections and, after hemodynamic and electrocardiographic changes returned to baseline (generally 0.5-2 minutes), was resubmerged for the next oblique view. The arteriogram was usually obtained after 1.5-2 minutes of cold submersion. Both coronary arteries were studied during cold pressor stimulation. Nitroglycerin was then administered sublingually and selected additional arteriograms were obtained. Left ventriculography was performed after selective coronary arteriography. Atropine was not used in any of the patients.
In eight patients, an initial dose of 0. The coronary arteriograms were analyzed by at least two observers. When the two observers did not agree, a third observer was consulted. Coronary artery spasm induced by the cold pressor test was considered to be present if a lesion observed in the control arteriograms progressed to complete (100%) or subtotal (95-99% diameter narrowing) occlusion on cold pressor stimulation or a noncritical lesion became critical (i.e., greater than 50% diameter narrowing) by an increase of at least 25% after cold pressor stimulation. Relief of the spasm by sublingual nitroglycerin was necessary to confirm the finding.
Quantitative coronary arteriography was performed using a Vanguard projector system equipped with a sonic digitizer and Tektronix 31 computer; the system was programmed to measure linear distances.
The coronary arteriogram was projected and an enddiastolic frame was selected. The projected luminal diameter of the coronary artery was measured separately by two observers. Measurements were made at a segment of the coronary artery that appeared angiographically normal. Each observer made five measurements at the same location on the vessel, usually at a branch point for reproducibility, and the measurements were averaged. Each coronary artery was measured before and after cold pressor stimulation and after nitroglycerin. Alterations in luminal diameter at the site of stenotic atheromatous lesions were measured in 12 arteries at the point of maximal stenosis. The quantitative angiographic responses to cold pressor stimulation and nitroglycerin were calculated as the percentage of change from control. The height of the image intensifier tower was kept constant during the study and the same oblique projections were used. Hence, changes in measured arterial diameter reflect changes in luminal caliber induced by the intervention.
Statistical comparisons were made using the t test.
Results

Hemodynamic Response
Hemodynamic measurements for the total group and the three subgroups are shown in table 1. Aortic systolic pressure increased significantly for all groups during cold pressor stimulation, with a mean increase of 18.1 ± 9.7 mm Hg (sD) (p < 0.001). Heart rate did not change significantly from baseline for the total group (3.4 ± 5.1 beats/min, p > 0.05). There were no significant differences between any two groups with regard to baseline aortic systolic and diastolic pressures, heart rate, double product and left ventricular end-diastolic pressure. The only significant intergroup difference in response to the cold pressor test was the change in systolic pressure of group 2 vs group 3 (p < 0.05).
Arteriographic Response (Focal Spasm) The angiographic responses of the three groups of patients to the cold pressor test are shown in table 2. Four of the six patients in group 1 manifested focal coronary artery spasm during the cold pressor test (figs. 1-3). In each case, spasm developed at the site of an atheromatous plaque. Two patients did not develop spasm during the cold pressor test.
Two of the 14 patients in group 2 manifested focal coronary artery spasm during the cold pressor test. Patient JW had only a 25% lesion in the right coronary artery despite having classic effort angina and exercise-induced ST-segment depression on treadmill exercise testing. The remaining 12 patients in this group had critical lesions in one or more vessels but none manifested focal spasm during the cold pressor test.
One of the 15 patients in group 3 manifested focal spasm at the site of a minor luminal plaque during cold pressor stimulation. Thirteen of the 14 non- Values'are mean -SD (range in parentheses).
Abbreviation: LVEDP = left ventricular end-diastolic pressure. responders had normal coronary arteriograms; one subject had two-vessel disease.
Baseline measurements and the hemodynamic response to cold pressor stimulation in the subjects who manifested coronary artery spasm did not differ significantly from those in patients who did not manifest coronary artery spasm.
Comparison of the Cold Pressor Test and Ergonovine Maleate Stimulation
Three patients with variant angina (group 1) received both provocative tests. One patient manifested spasm to both stimuli, but the degree of spasm was more pronounced with ergonovine (100% vs 95%). One patient responded to ergonovine (60% occlusion) but had no focal response to cold pressor. Another patient with variant angina showed no response to either provocative tests but had been given S mg of sublingual isosorbide dinitrate for severe chest pain 45 minutes before arteriography, which may have contributed to his failure to respond to provocation. Two patients with classic angina (group 2) underwent both tests. One patient responded to both but with greater narrowing after ergonovine (95% vs 75%), whereas the other patient did not respond to either stimulus. Three patients with atypical chest pain (group 3) showed no focal response to either provocative test. between cold pressor and nitroglycerin, was similar for each group (21.5 ± 15.6%, 20.5 ± 13.4% and 26.4 ± 14.1% of control for groups 1, 2 and 3, respectively. Alteration in luminal diameter at the site of fixed atheromatous disease was observed with cold pressor stimulation and nitroglycerin (table 3) . Although the mean changes were not statistically significant, the luminal diameter in eight of 12 lesions (67%) decreased during the cold pressor test. After nitroglycerin, seven of 12 lesions (59%) increased in diameter.
Discussion
The diagnosis of coronary artery spasm is often difficult. The likelihood of observing spontaneous coronary artery spasm during coronary arteriography is diminished because arteriographic observation is short, angiographic contrast media are vasodilators, and subjects are routinely premedicated with nitroglycerin.'6 Attempts to induce coronary artery spasm with pharmacologic agents have been rewarding. Ergot alkaloids,"'2 epinephrine in combination with propranolol," and methacholine'4 have been shown to produce coronary artery spasm in patients with variant angina. The ergot alkaloids appear to act directly on vascular smooth muscle to produce vasoconstriction." Epinephrine stimulates ce-adrenergic receptors in the coronary vascular bed and propranolol blocks the f, receptors that cause vasodilation. 13 Methacholine, a parasympathomimetic agent, induces hypotension; Endo et al. '4 suggested that coronary artery spasm occurs as a result of reflex sympathetic stimulation secondary to the hypotension. These pharmacologic agents may produce undesirable side effects, particularly in patients with severe coronary artery disease.
An easily performed and safe provocative test that does not require the administration of pharmacologic agents would be of value as a first line attempt to provoke spasm, particularly in patients with coronary artery disease. We believe that the cold pressor test may offer this potential. The cold pressor test is relatively simple to perform, and the response to cold occurs rapidly (approximately 1 minute) and is readily reversed by discontinuing the cold stimulus and administering nitroglycerin. The arterial pressure changes we observed were mild or moderate; however, arterial pressure must be continuously monitored because of the possibility of a exaggerated pressor response.'7, Ventricular ectopy and ventricular tachycardia the only complications resulting from the cold pressor test in our series -occurred in one patient during the induced ischemia, but were readily reversed after i.v. nitroglycerin. The safety of the test is supported by studies that included patients with critical multivessel atheromatous coronary artery disease. '5-19 We have, nevertheless, avoided using this test in patients with left main coronary artery disease.
The cold pressor test has been used as a reflexogenic stimulus for assessing cardiovascular reactivity.17 Cold pressor stimulation induces reflex vasoconstriction of multiple vascular beds with a consequent increase in peripheral vascular resistance and systemic arterial blood pressure.20 The cold pressor test is known to provoke angina'9 21 and has been shown to reduce coronary blood flow in some patients with coronary artery disease.15 Although the mechanism of this response is not clear, reflex vasoconstriction of the coronary vascular bed has been suggested."
The present study shows that the cold pressor test provokes generalized coronary vasoconstriction in most patients and can provoke focal spasm of the coronary vasculature in some. In our patients, focal spasm occured primarily in the vicinity of atheromatous disease. In two of seven patients, focal spasm was associated with some manifestation of myocardial ischemia. The hemodynamic response to the cold pressor test is an increase in arterial blood pressure; '7, 20 hence, myocardial ischemia may result from increased myocardial oxygen demand and does not necessarily indicate coronary artery spasm. Therefore, the angiographic demonstration of transient and reversible coronary artery narrowing is necessary to implicate spasm. Both an increased myocardial oxygen demand and a transiently diminished supply (spasm) probably contribute to ischemic manifestations in these patients.
The clinical significance of coronary artery spasm without myocardial ischemia, present in five of our patients, is unclear. We monitored only two limb leads during routine coronary arteriography; other leads, particularly precordial leads, might have revealed ischemic ST-segment changes. It is also possible that coronary spasm of insufficient severity or duration to produce myocardial ischemia can occur. The brevity of the cold pressor stimulus may limit its likelihood of provoking clinical manifestations of ischemia. We have seen patients with typical variant angina who had spontaneous coronary artery spasm during arteriography but who did not have concurrent chest pain or electrocardiographic abnormalities. Consequently, we speculate that the arteriographic demonstration of coronary artery spasm, even without associated ischemic manifestations, may indicate a pathophysiologic abnormality that could, at other times, produce myocardial ischemia.
The cold pressor test provoked coronary artery spasm in four of the six patients with variant angina and thus may be an important adjunct in detecting and documenting coronary spasm in this group of patients. In each of the four positive responders, the spasm developed at the site of an atheromatous plaque. Two patients with typical clinical manifestations of variant angina and normal coronary arteries did not manifest focal spasm during cold pressor stimulation. Thus, a negative cold pressor test does not exclude the diagnosis of variant angina. One of these patients responded to ergonovine; the other responded to neither cold pressor stimulation nor ergonovine maleate, but had been having frequent severe attacks and was given sublingual isosorbide dinitrate just before study, which may have prevented the occurrence of spasm.
Three patients did not have clinical evidence of variant angina, but manifested spasm during the cold pressor test. There is strong evidence that spasm may play a role in ischemic heart diseases other than variant angina. Reports of spasm in patients with classic angina,6'7 unstable angina8' 9 The very definition of coronary artery spasm is unsettled. Although coronary artery spasm is regarded as a pathologic phenomenon, continuous alteration in vasomotor tone is a normal characteristic of arteries. Alterations in vasomotor tone are to a great extent influenced by the sympathetic nervous system. By stimulating the sympathetic nervous system, the cold pressor test can significantly alter coronary artery diameter, as shown in this study using quantitative arteriography. Further, coronary vasomotion was seen in patients with atypical chest pain and classic angina, as well as in those with variant angina. The distinction between normal coronary vasomotion and pathologic coronary artery spasm may be difficult and arbitrary. Rather, there appears to be a spectrum of vascular reactivity, with the coronary arteries of variant angina patients being more reactive (table 3) .
Nevertheless, coronary arteries that have atherosclerotic lesions are still capable of vasomotion in normal segments and at the lesion site, and normal or exaggerated vasomotion might further compromise the lumen. This process may occur more frequently than appreciated in patients with coronary atheromatous disease.
We did not evaluate the relative merits of the cold pressor stimulus and ergonovine maleate as provocative tests. Nonetheless, data were obtained in eight patients given both tests. Ergonovine maleate precipitated focal coronary spasm in one patient with variant angina who did not respond to cold pressor and produced more severe spasm in a group 2 patient with classic angina who responded to the cold pressor test. These findings suggest that ergonovine is a more potent provoker of coronary spasm. Ergonovine-induced spasm is associated with ischemic manifestations, sometimes to a frightening degree,23 and it is particularly helpful in evaluating the patient with chest pain suggestive of ischemia who has normal or insignificantly diseased coronary arteries. We avoid its use in patients with critical coronary artery lesions.
In this study, the cold pressor test precipitated coronary artery spasm with few complications. Although these results are encouraging, we cannot determine from this study what percentage of patients with coronary artery spasm can be identified by this approach. We recommend that the cold pressor test be tried before other pharmacologic attempts at provoking spasm, particularly in patients with coronary atherosclerotic disease. More extensive evaluation in larger groups of subjects under careful control observation is warranted before the efficacy of the test as a provocative maneuver can be established.
